Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-25 @ 2:18 AM
NCT ID:
NCT04164134
Eligibility Criteria:
Inclusion Criteria:
Adult (16 years and older):
* Group 1: germline mutation RB1.
* Group 2 (control): no germline mutation RB1.
Pediatric (until 6 years of age):
* Group 1: somatic or germline mutation RB1 and retinoblastoma.
* Group 2 (control): no mutation RB1.
Exclusion Criteria:
Adult (16 years and older):
* Group 1: concomitant heritable (inherited) disorder other than caused by monoallelic mutation of RB1.
* Group 2 (control): cancer or already known cancer predisposition syndrome.
Pediatric (until 6 years of age):
* Group 1: concomitant heritable (inherited) disorder other than caused by monoallelic mutation of RB1.
* Group 2: cancer or already known cancer predisposition syndrome.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
99 Years
Study:
NCT04164134
Study Brief:
Protocol Section:
NCT04164134